Market cap
$107 Mln
Revenue (TTM)
$513 Mln
P/E Ratio
--
P/B Ratio
1.4
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -13.35 | -18.89 | -2.02 | -3.48 | 1.79 |
| EBIT | -22.10 | 69.03 | 72.68 | 24.76 | 13.71 |
| Net Profit | -15.15 | -29.42 | 75.23 | 24.59 | 13.55 |
| EPS | -14.68 | -32.40 | 63.67 | 24.63 | 13.81 |
| Book Value | -- | -- | 9,371.74 | -23.26 | -26.18 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -64.55 | -104.43 | -10.13 | -9.96 | -62.51 |
| Net Margin
| -- | -- | -11.53 | -- | -- |
| Return on equity
| -43.05 | -46.23 | -11.09 | -9.91 | -51.38 |
| Return on Capital
| -41.29 | -44.38 | -- | -9.13 | -49.03 |
| Return on Assets
| -30.75 | -34.95 | -5.56 | -6.49 | -36.01 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.08 | 0.09 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
--
|
-9.13
|
-49.03
|
-65.70
|
-61.84
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-11.09
Lower than Peers by 19.05
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
-11.09
|
-9.91
|
-51.38
|
-67.85
|
-64.67
|
|
Peer Median
|
7.96
|
--
|
--
|
--
|
--
|
ROA
-5.56
Lower than Peers by 7.70
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
-5.56
|
-6.49
|
-36.01
|
-49.76
|
-50.24
|
|
Peer Median
|
2.14
|
--
|
--
|
--
|
--
|
EBIT Margin
-10.13
Lower than Peers by 17.19
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
-10.13
|
-9.96
|
-62.51
|
-121.19
|
-172.08
|
|
Peer Median
|
7.06
|
--
|
--
|
--
|
--
|
Net Margin
-11.53
Lower than Peers by 14.68
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
-11.53
|
-10.26
|
-67.20
|
-121.63
|
-172.44
|
|
Peer Median
|
3.16
|
--
|
--
|
--
|
--
|
Revenue Growth
-2.02
Lower than Peers by 11.86
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
-2.02
|
0.05
|
-0.04
|
-0.05
|
0.11
|
|
Peer Median
|
9.83
|
--
|
--
|
--
|
--
|
EBIT Growth
72.68
Higher than Peers by 56.48
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
72.68
|
83.33
|
50.49
|
32.80
|
-22.03
|
|
Peer Median
|
16.21
|
--
|
--
|
--
|
--
|
Net Profit Growth
75.23
Higher than Peers by 58.04
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
75.23
|
84.03
|
46.97
|
32.69
|
-21.91
|
|
Peer Median
|
17.18
|
--
|
--
|
--
|
--
|
EPS Growth
63.67
Higher than Peers by 47.58
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
63.67
|
-15.40
|
0.99
|
0.33
|
-0.24
|
|
Peer Median
|
16.10
|
--
|
--
|
--
|
--
|
Book Value Growth
-7.60
Lower than Peers by 12.72
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
-7.60
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.12
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.00
Lower than Peers by 0.38
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
0.00
|
0.08
|
0.09
|
0.02
|
0.04
|
|
Peer Median
|
0.38
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.04
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
0.04
|
0.03
|
0.04
|
0.01
|
0.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
3.05
Higher than Peers by 1.57
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
3.05
|
2.99
|
2.92
|
3.36
|
3.06
|
|
Peer Median
|
1.48
|
--
|
--
|
--
|
--
|
Quick Ratio
2.81
Higher than Peers by 1.43
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
2.81
|
2.76
|
2.71
|
3.09
|
2.74
|
|
Peer Median
|
1.38
|
--
|
--
|
--
|
--
|
Interest Coverage
-1,283.91
Lower than Peers by 1,288.23
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
-1,283.91
|
-1,792.00
|
--
|
--
|
-86.86
|
|
Peer Median
|
4.32
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
34.57
Higher than Peers by 21.44
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
34.57
|
33.74
|
33.63
|
27.84
|
30.22
|
|
Peer Median
|
13.12
|
--
|
--
|
--
|
--
|
Asset Turnover
0.48
Lower than Peers by 0.29
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
0.48
|
0.63
|
0.54
|
0.41
|
0.29
|
|
Peer Median
|
0.78
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
--
|
120.32
|
114.38
|
108.68
|
107.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
--
|
148.04
|
146.15
|
208.97
|
252.74
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
--
|
99.58
|
61.67
|
72.34
|
113.67
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Burning Rock Biotech (BNR)
|
--
|
168.77
|
198.86
|
245.31
|
246.61
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|